+64.1%
CVS vs SARO
-22.5%
+86.6%
-34.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | SARO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | +1.6% | -2.3% | -0.8% |
| 7D | -2.2% | -3.1% | +1.0% | -1.8% |
| 30D | -0.1% | -12.2% | +12.2% | +1.3% |
| 3M | -5.2% | -7.4% | +2.2% | -4.7% |
| 6M | +26.9% | -15.3% | +42.2% | +28.4% |
| YTD | +22.1% | -16.2% | +38.2% | +23.0% |
| 1Y | +30.8% | -12.1% | +42.9% | +30.6% |
| All | +64.1% | -22.5% | +86.6% | +66.4% |
Cumulative growth
Daily Returns
Daily percentage return beside SARO.
Daily Out/Under-Performance
Portfolio return minus SARO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SARO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded SARO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling